(AEE) Ameren - Overview
Sector: Utilities | Industry: Utilities - Regulated Electric | Exchange: NYSE (USA) | Market Cap: 30.800m USD | Total Return: 15.5% in 12m
Avg Turnover: 202M
EPS Trend: 91.6%
Qual. Beats: 3
Rev. Trend: 65.0%
Qual. Beats: 0
Warnings
High Debt while negative Cash Flow
Altman Z'' 0.87 < 1.0 - financial distress zone
Below Avwap Earnings
Tailwinds
No distinct edge detected
Ameren Corporation (NYSE: AEE) is a Saint Louis-based public utility holding company operating rate-regulated electric and natural gas businesses across Missouri and Illinois. The company manages a diversified energy portfolio including coal, nuclear, natural gas, and renewable sources such as wind and solar.
As a regulated utility, Ameren operates under a cost-of-service model where state and federal commissions set rates, providing a degree of revenue predictability compared to non-regulated sectors. Multi-utilities like Ameren typically require high capital expenditure for infrastructure maintenance and grid modernization in exchange for geographic monopolies.
To evaluate how these regulatory tailwinds impact long-term valuation, consider reviewing the detailed metrics on ValueRay. Ameren serves a broad base of residential, commercial, and industrial customers through four distinct segments focused on transmission and distribution.
- Rate-regulated utility investments drive steady rate base growth and earnings predictability
- Transition to renewable energy assets increases capital expenditure and regulatory recovery risk
- Interest rate fluctuations impact cost of debt for large scale infrastructure projects
- Missouri and Illinois regulatory environments dictate allowed return on equity and margins
- Coal-to-clean energy shift creates long-term transmission and distribution investment opportunities
| Net Income: 1.52b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.03 > 0.02 and ΔFCF/TA 1.52 > 1.0 |
| NWC/Revenue: -17.56% < 20% (prev -5.16%; Δ -12.40% < -1%) |
| CFO/TA 0.07 > 3% & CFO 3.34b > Net Income 1.52b |
| Net Debt (20.1b) to EBITDA (3.91b): 5.14 < 3 |
| Current Ratio: 0.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (278.4m) vs 12m ago 2.58% < -2% |
| Gross Margin: 39.38% > 18% (prev 0.47%; Δ 3.89k% > 0.5%) |
| Asset Turnover: 18.59% > 50% (prev 17.31%; Δ 1.28% > 0%) |
| Interest Coverage Ratio: 2.86 > 6 (EBITDA TTM 3.91b / Interest Expense TTM 805.0m) |
| A: -0.03 (Total Current Assets 2.57b - Total Current Liabilities 4.13b) / Total Assets 49.8b |
| B: 0.11 (Retained Earnings 5.44b / Total Assets 49.8b) |
| C: 0.05 (EBIT TTM 2.30b / Avg Total Assets 47.8b) |
| D: 0.37 (Book Value of Equity 13.6b / Total Liabilities 36.2b) |
| Altman-Z'' = 0.87 = B |
| DSRI: 0.50 (Receivables 703.0m/1.25b, Revenue 8.88b/7.90b) |
| GMI: 1.20 (GM 39.38% / 47.15%) |
| AQI: 1.01 (AQ_t 0.14 / AQ_t-1 0.14) |
| SGI: 1.12 (Revenue 8.88b / 7.90b) |
| TATA: -0.04 (NI 1.52b - CFO 3.34b) / TA 49.8b) |
| Beneish M = -3.20 (Cap -4..+1) = AA |
As of May 30, 2026, the stock is trading at USD 107.97 with a total of 3,903,116 shares traded.
Over the past week, the price has changed by -1.70%,
over one month by -2.98%,
over three months by -4.04% and
over the past year by +15.52%.
Ameren has received a consensus analysts rating of 3.88. Therefore, it is recommended to buy AEE.
- StrongBuy: 8
- Buy: 1
- Hold: 6
- Sell: 2
- StrongSell: 0
| Analysts Target Price | 119.8 | 11% |
P/E Trailing = 20.0162
P/E Forward = 20.5339
P/S = 3.6044
P/B = 2.2424
P/EG = 2.5648
Revenue TTM = 8.88b USD
EBIT TTM = 2.30b USD
EBITDA TTM = 3.91b USD
Long Term Debt = 19.0b USD (from longTermDebt, last quarter)
Short Term Debt = 1.12b USD (from shortTermDebt, last quarter)
Debt = 20.1b USD (corrected: LT Debt 19.0b + ST Debt 1.12b)
Net Debt = 20.1b USD (calculated: Debt 20.1b - CCE 13.0m)
Enterprise Value = 50.9b USD (30.8b + Debt 20.1b - CCE 13.0m)
Interest Coverage Ratio = 2.86 (Ebit TTM 2.30b / Interest Expense TTM 805.0m)
EV/FCF = -39.07x (Enterprise Value 50.9b / FCF TTM -1.30b)
FCF Yield = -2.56% (FCF TTM -1.30b / Enterprise Value 50.9b)
FCF Margin = -14.68% (FCF TTM -1.30b / Revenue TTM 8.88b)
Net Margin = 17.17% (Net Income TTM 1.52b / Revenue TTM 8.88b)
Gross Margin = 39.38% ((Revenue TTM 8.88b - Cost of Revenue TTM 5.38b) / Revenue TTM)
Gross Margin QoQ = 49.68% (prev 27.95%)
Tobins Q-Ratio = 1.02 (Enterprise Value 50.9b / Total Assets 49.8b)
Interest Expense / Debt = 4.00% (Interest Expense 805.0m / Debt 20.1b)
Taxrate = 14.59% (61.0m / 418.0m)
NOPAT = 1.96b (EBIT 2.30b * (1 - 14.59%))
Current Ratio = 0.62 (Total Current Assets 2.57b / Total Current Liabilities 4.13b)
Debt / Equity = 1.48 (Debt 20.1b / totalStockholderEquity, last quarter 13.6b)
Debt / EBITDA = 5.14 (Net Debt 20.1b / EBITDA 3.91b)
Debt / FCF = -15.44 (negative FCF - burning cash) (Net Debt 20.1b / FCF TTM -1.30b)
Total Stockholder Equity = 13.0b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.19% (Net Income 1.52b / Total Assets 49.8b)
RoE = 11.71% (Net Income TTM 1.52b / Total Stockholder Equity 13.0b)
RoCE = 7.18% (EBIT 2.30b / Capital Employed (Equity 13.0b + L.T.Debt 19.0b))
RoIC = 4.19% (NOPAT 1.96b / Invested Capital 46.8b)
WACC = 5.11% (E(30.8b)/V(50.9b) * Re(6.22%) + D(20.1b)/V(50.9b) * Rd(4.00%) * (1-Tc(0.15)))
Discount Rate = 6.22% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 98.88 | Cagr: 2.39%
[DCF] Fair Price = unknown (Cash Flow -1.30b)
EPS Correlation: 91.63 | EPS CAGR: 9.51% | SUE: 0.85 | # QB: 3
Revenue Correlation: 65.03 | Revenue CAGR: 6.01% | SUE: -0.27 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.06 | Chg30d=-4.64% | Revisions=-20% | Analysts=3
EPS next Quarter (2026-09-30): EPS=2.43 | Chg30d=+0.41% | Revisions=+20% | Analysts=3
EPS current Year (2026-12-31): EPS=5.37 | Chg30d=-0.09% | Revisions=+25% | GrowthEPS=+0.4% | GrowthRev=+5.8%
EPS next Year (2027-12-31): EPS=5.84 | Chg30d=+0.00% | Revisions=+43% | GrowthEPS=+8.7% | GrowthRev=+5.3%
[Analyst] Revisions Ratio: +43%